Drug Companies Raising Prices Ahead Of Reform
Even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislatio...
Even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislatio...
New York Times | DUFF WILSON | Posted 11.15.2009 | Business
Even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislatio...
Richard T. Clark | Posted 11.04.2009 | Business
We now have people in more countries, including more emerging markets, and are putting systems in place to create and incubate knowledge networks which were unattainable just a few years ago.
Marcia G. Yerman | Posted 11.05.2009 | Living
As the nation's attention is riveted on the discourse about health care reform, another debate is taking place around the Gardasil vaccine.
Abby L. Ferber | Posted 10.27.2009 | Living
Last Friday, the FDA approved the HPV vaccine for use in boys and men. Why is Gardasil only now being approved for males, when it was approved three years ago for females?
Wall Street Journal | JANET ADAMY and GREG HITT | Posted 10.19.2009 | Politics
The drug industry stands to gain in a health-care overhaul by getting tens of millions of newly insured customers, while insurance companies -- especi...
Jeff Kreisler | Posted 10.21.2009 | Comedy
So, let me get this straight: Pfizer is the drug company who'll lie to you, but Merck's the one that'll kill you?
wired.com | STEVE SILBERMAN | Posted 09.28.2009 | Living
Merck was in trouble. In 2002, the pharmaceutical giant was falling behind its rivals in sales. Even worse, patents on five blockbuster drugs were abo...
Mike Papantonio | Posted 08.27.2009 | Politics
There will be no serious health care reform until the drug companies, the hospital corporations and the HMO industry are forced to pay their share of the bill.
Charles Warner | Posted 08.16.2009 | Media
The nation's journal of record; America's first draft of history; the Grey Lady, -- the New York Times -- got it wrong and that the crowd-sourced, open-source, oft-criticized Wikipedia got it right.
Deborah Burger | Posted 07.16.2009 | Politics
All in all, it seems a safe bet that in the final analysis, we may yet end up with the best health care reform money can buy.
AP | LINDA A. JOHNSON | Posted 05.22.2009 | Business
TRENTON, N.J. — Drugmaker Merck & Co. on Tuesday posted a 57 percent drop in first-quarter profit, falling short of expectations and sending its...
James Floyd, M.D. | Posted 03.06.2009 | Politics
Gupta downplays safety risks in treatments, and was criticized for his reporting on Vioxx, a pain medication that was withdrawn from the market in 2004 because it causes heart attacks.
AP | LINDA A. JOHNSON | Posted 11.22.2008 | Business
TRENTON, N.J. — Drugmaker Merck & Co. said Wednesday it will slash 7,200 jobs as part of a new restructuring program that comes as its third-qua...
AP | MARTHA RAFFAELE | Posted 05.28.2008 | Business
HARRISBURG, Pa. — Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular ...
AP | DAMIAN TROISE | Posted 04.08.2008 | Business
NEW YORK — Shares of Merck & Co. and Schering-Plough Corp. fell to record lows Monday, as analysts warned new clinical data would choke sales of...
AP | MATTHEW PERRONE | Posted 04.04.2008 | Business
WASHINGTON — The Food and Drug Administration said Thursday it is investigating a possible link between Merck's best-selling Singulair and suici...
AP | LINDA A. JOHNSON | Posted 03.28.2008 | Business
TRENTON, N.J. — In one of the biggest U.S. health care fraud settlements ever, Merck & Co. will pay $671 million to settle claims it overcharged...
New York Times | Alex Berenson | Posted 03.28.2008 | Business
Three years after withdrawing its pain medication Vioxx from the market, Merck has agreed to pay $4.85 billion to settle 27,000 lawsuits by people who...
CNN/Money | Aaron Smith | Posted 03.28.2008 | Business
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said t...
AP | LINDA A. JOHNSON | Posted 03.28.2008 | Business
A promising experimental vaccine to prevent the AIDS virus has failed in a crucial experiment, with volunteers becoming infected with HIV anyway, lead...
nytimes.com | DUFF WILSON | Posted 11.16.2009 | Business